The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry
Editor's Note: The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry - Michael E. Thase, MD
If you didn't find what you were looking for, try a new search!
Editor's Note: The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry - Michael E. Thase, MD
Jodi M. Gonzalez, PhD ORIGINAL RESEARCH Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder Jodi M. Gonzalez, PhD, Peter Thompson, MD, Michael Escamilla, MD, Mako Araga, MS, Vivek Singh, MD, Niamh Farrelly, MD, Michael E. Thase, MD, [...]
Screening of Pregnant Women and New Mothers a Priority January 26, 2016. CNN reports this morning that if new recommendations by the U.S. Preventive Services Task Force are followed, primary care physicians will do this type of depression screening for all adult patients at least once. The recommendations by the task [...]
Abstract Many studies indicate a crucial role for the vitamin B12 and folate-dependent enzyme methionine synthase (MS) in brain development and function, but vitamin B12 status in the brain across the lifespan has not been previously investigated. Vitamin B12 (cobalamin, Cbl) exists in multiple forms, including methylcobalamin (MeCbl) and adenosylcobalamin [...]
EVIDENCE-BASED MEDICINE Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy By Michael E. Thase, MD
ORIGINAL RESEARCH Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data By Mark A. Demitrack, Michael E. Thase
EVIDENCE-BASED MEDICINE Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior? Alan G. Mallinger, Ellen Frank, Michael E. Thase, Michelle M. Barwell, Nancy DiazGranados, David A. Luck
For Immediate Release December 31, 2015. Los Angeles CA Contact: James La Rossa Jr., 310.374.1300 MedWorks Media Inc., established in 1994 as one of the largest publishers of journals and educational medical projects about psychiatric medicine, was reconfigured for a 2016 launch as a cutting-edge digital portal and publisher — [...]
Joyce E. Myers, MD GENERAL PSYCHOPHARMACOLOGY Review of Its Therapeutic Utility in Depression Joyce E. Myers, MD, and Michael E. Thase, MD
Ripu D. Jindal, MD GENERAL PSYCHOPHARMACOLOGY Effects of Tranylcypromine on the Sleep of Patients with Anergic Bipolar Depression Ripu D. Jindal, MD, Amy L. Fasiczka, MA, Jonathan M. Himmelhoch, MD, Alan G. Mallinger, MD, and Michael E. Thase, MD
Mikael Landén, MD, PhD GENERAL PSYCHOPHARMACOLOGY A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors Mikael Landén, MD, PhD, and Michael E. Thase, MD
Mark S. Bauer, MD ORIGINAL RESEARCH Brief Report: Paroxetine in Younger and Adult Individuals at High Risk for Suicide Mark S. Bauer, MD, Stephen R. Wisniewski, PhD, Jane N. Kogan, PhD, Lauren B. Marangell, MD, Michael E. Thase, MD, Gary Sachs, MD, for the STEP-BD Investigators
Gender-Specific Differences in Depression and Treatment Response By Susan G. Kornstein, MD, Diane M. E. Sloan, PharmD, and Michael E. Thase, MD
Remission as the Critical Outcome of Depression Treatment By Michael E. Thase, MD, Diane M. E. Sloan, PharmD, and Susan G. Kornstein, MD
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder By Michael E. Thase, MD, and Madhukar Trivedi, MD
Comparing the Methods Used to Compare Antidepressants By Michael E. Thase, MD